Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Wassmann

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
European Journal of Heart Failure|March 17, 2025
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESCDavide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
European Journal of Heart Failure|November 10, 2025
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular PharmacotherapyGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 27, 2021
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma Forton Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
European Journal of Heart Failure|March 17, 2025
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESCDavide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
European Journal of Heart Failure|November 10, 2025
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular PharmacotherapyGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
Pageof 8